Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MDCX is expected to report earnings to rise 96.77% to -61 cents per share on August 20
Q2'26
Est.
$-0.61
Q1'26
Beat
by $0.30
Q4'25
Missed
by $0.38
Q3'25
Missed
by $0.90
Q2'25
Missed
by $0.18
The last earnings report on May 14 showed earnings per share of -31 cents, beating the estimate of -61 cents. With 780.05K shares outstanding, the current market capitalization sits at 25.20M.